Natural history of hepatitis C and outcomes following liver transplantation

This publication has 57 references indexed in Scilit:

• Anti-HCV human immunoglobulins for the prevention of graft infection in HCV-related liver transplantation, a pilot study
  Journal of Hepatology, 2002
• Pegylated (40kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
  Gastroenterology, 2001
• Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation
  Liver Transplantation, 2000
• The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
  Science, 2000
• Recurrent and New Hepatitis C Virus Infection After Liver Transplantation
  Hepatology, 1999
• Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection
  Gastroenterology, 1998
• Long-term outcome of hepatitis C virus infection after liver transplantation
  Hepatology, 1997
• Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation
  Hepatology, 1995
• The prevalence of hepatitis C virus (HCV) in infants and children after liver transplantation
  Digestive Diseases and Sciences, 1994
• Liver transplantation for hepatitis C virus-related cirrhosis
  Hepatology, 1994